Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

639.53
Delayed Data
As of Jul 07
 +13.63 / +2.17%
Today’s Change
271.37
Today|||52-Week Range
653.53
+70.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues4.1B4.9B5.9B6.7B
 
 
 
 
 
Cost of Goods Sold392.7M299.7M397.1M434.1M
 
 
 
 
 
Depreciation And Amortization74.9M104.7M145.5M148.2M
 
 
 
 
 
 
Operating ExpensesGross Income3.6B4.5B5.3B6.1B
 
 
 
 
 
General Expenses2.4B3.1B3.3B3.6B
 
 
 
 
 
Research And Development1.5B1.9B1.9B2.0B
 
 
 
 
 
Total Operating Expenses2.9B3.5B3.8B4.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3B1.3B2.1B2.5B
 
 
 
 
 
Extraordinary Charge-18.9M-9.8M-30.1M-41.9M
 
 
 
 
 
Interest Expense On Debt14.2M7.2M25.1M28.2M
 
 
 
 
 
Other Expenses0.0016.1M54.1M89.2M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.2B1.3B2.1B2.6B
 
 
 
 
 
Income Taxes-589.0M-434.3M-880.0M-109.1M
 
 
 
 
 
Net Income636.1M895.5M1.2B2.4B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.1M104.7M106.3M107.9M
 
 
 
 
 
Shares To Calculate EPS Diluted115.2M116.4M116.0M114.8M
 
 
 
 
 
 
Earnings Per ShareEPS$5.52$7.70$10.34$21.29
 
 
 
 
 
EPS Diluted$5.52$7.70$10.34$21.29